|
2000/2001 Research Operating Funds |
|
2000/2001 Research Operating Funds |
| INVESTIGATORS | AGENCY | YEAR | AMOUNT |
| ELEANOR ELSTEIN | Medical
Research Council of Canada (Co-applicant) |
2000-2001 | $ 71,247/yr |
| WILLIAM FOULKES | National
Cancer Institute of Canada ( Principal Investigator) |
1999-2002 | $ 100,667/yr |
| US Army | 1999-2002 | $ 95,667 US/yr |
|
| US Army | 1yr (FY00 award) | $ 50,000 US |
|
| National Cancer Institute of Canada (Co-investigator) - Group grant | 2000-2003 | $ 10,000/yr | |
| BRIAN GILFIX | Fonds da
la recherche en santé du Québec, |
2000 - 2001 | $ 5,
000/yr |
| THOMAS HUDSON | Canada
Foundation for Innovation and matching funds from Government |
April 1999 – June 2003 | $8,250,000 |
| Bristol-Myers Squibb, Millennium Pharmaceuticals Inc., Affymetrix (Whitehead Institute subcontract - Industrial Award): | July 1999 – June 2000 | $ 500,000 US/yr | |
| Medical Research Council of Canada (Operating grant): | April 1999 - Sept 2001 | $ 132,744/yr | |
| Medical Research Council of Canada (Operating Grant) T.J. Hudson’s allocation | Oct 1999 – Sept 2002 | $ 43,000/yr | |
| Networks
of Centres of Excellence - Phase III Canadian Genetic Diseases Network [CGDN]: M. Hayden and the members of the CGDN (Thomas J. Hudson, P.I.) |
April 1998-March 2005 | ||
| 1) Core Facility - genotyping | 1998-2000 | $ 95,563/yr | |
| |
$156,613/yr | ||
| 2001-2005 | approx $ 95,563/yr | ||
| 2) Expression studies using high-density DNA arrays: | 1998-2000 | $ 98,566/yr | |
| 2000-2001 | $ 113,000/yr |
||
| 2001-2005 | approx $ 98,566/yr | ||
| Networks
of Centres of Excellence – Phase II Canadian Arthritis Network Dr. Hudson’s allocation: |
April 1999- March 2001 | $ 24,000/yr | |
| Multiple
Sclerosis Foundation (Program Grant) |
April 2000 to March 2003 | $ 69,000/yr | |
| Montreal
Breast Cancer Foundation (co-investigator) |
March 2000 - May 2000 | $ 35,000/yr | |
| June 2000 - May 2001 | $ 35,000/yr | ||
| US Army - Prostate Cancer Opportunities (Group grant) | Sept. 1999 – Aug. 2000 | $ 2,000 US/yr | |
| Sept. 2000 – Aug. 2001 | $ 2,000 US/yr | ||
| Sept. 2001 – Aug. 2002 | $ 17,000 US/yr | ||
| Social
Sciences and Humanities Research Council of Canada (Group grant) |
Jan.2001 - Dec.2005 | $3,210,297 | |
| National
Institute of Health - Operating Grant ) |
March 1998 - June 2000 | $2,607,695 US/ yr | |
| KENNETH MORGAN | Networks
of Centres of Excellence (Investigator) |
2000-2001 | $ 165,100/yr |
| Medical
Research Council of Canada (co-applicant) |
2000-2001 | $ 132,744/yr |
|
| Networks
of Centres of Excellence (Investigator) |
2000-2001 | $ 25,800/yr |
|
| additional from MGHRI as partner | $ 19,733/yr | ||
| Canada
Foundation for Innovation (Team member) |
Amount awarded: | (See information from Tom Hudson) |
|
| DAVID S. ROSENBLATT | Medical
Research Council of Canada - Genetics Group |
1999-2000 | $ 91,426/yr |
| NIH Group Grant | 1999-2000 | $ 17,857 US/yr |
|
| GUY ROULEAU | Fonds de
Recherche en Sante du Quebec DNA and lymphoblastoid cell bank for Quebec |
1998-2001 | $ 14,000/yr |
| National
Institutes of Health - Etiology of restless leg syndrome, a sleep disorder |
1999-2002 | $ 54,283 US/yr |
|
| Canadian Institutes of Health Research | 2000-2003 | $ 165,000/yr | |
| PATRICIA TONIN | April 1999 - March 2002 | $ 81,000/yr | |
| Canadian
Institute of Health Research (Co-investigator) |
Oct. 1999 -Sept. 2002 | $162,000/yr | |
| The Cancer Research Society, Inc. (Investigator) | Sept. 2000 - Aug 2002 | $ 50,000/yr | |
| Fonds de
la Recherche en Santé du Québec: Reseau cancerologie - Group Grant |
Jan. 2000 - July 2001 | $ 648,000/yr |
|
| Canadian
Foundation for Innovation (Investigator) University of Monteal - Host |
July 2000- | $ 999,463 | |
| Canadian
Breast Cancer Research Initiative (Co-investigator) |
July 1999 - June 2000 | $ 49,188 | |
| The CURE
Foundation (Investigator) |
Oct. 1999 - Sept. 2000 | $ 55,000/yr | |
(c) 2001 Finestone Laboratory
